| Title |
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
|
|---|---|
| Published in |
Risk Management and Healthcare Policy, August 2018
|
| DOI | 10.2147/rmhp.s168504 |
| Pubmed ID | |
| Authors |
Alyssa M Peckham, Maria J Ananickal, David A Sclar |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 50% |
| Japan | 1 | 8% |
| Saudi Arabia | 1 | 8% |
| Malaysia | 1 | 8% |
| Unknown | 3 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 75% |
| Practitioners (doctors, other healthcare professionals) | 2 | 17% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 73 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 10% |
| Student > Doctoral Student | 7 | 10% |
| Student > Ph. D. Student | 6 | 8% |
| Other | 6 | 8% |
| Student > Bachelor | 6 | 8% |
| Other | 14 | 19% |
| Unknown | 27 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 22% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 12% |
| Nursing and Health Professions | 4 | 5% |
| Psychology | 4 | 5% |
| Social Sciences | 3 | 4% |
| Other | 8 | 11% |
| Unknown | 29 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 59. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2023.
All research outputs
#712,314
of 25,195,876 outputs
Outputs from Risk Management and Healthcare Policy
#18
of 725 outputs
Outputs of similar age
#15,203
of 336,964 outputs
Outputs of similar age from Risk Management and Healthcare Policy
#2
of 5 outputs
Altmetric has tracked 25,195,876 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 725 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,964 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.